HANBQUIX

This brand name is authorized in Nigeria.

Active ingredients

The drug HANBQUIX contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII HTN0D03VRZ - LEVOFLOXACIN HYDROCHLORIDE
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7653	Tablet	HANBQUIX TABLET TAB 500 mg 110	HANBQUIX TABLET LEVOFLOXACIN LEVOFLOXACIN HYDROCHLORIDE 500MG, STARCH, TITANIUM DIOXIDE, MICROCRYSTALLINE CELLULOSE, MAGNESIUM STEARATE, POVIDONE B4-7653 Drugs Imported Products 110 Prescription Only Medicine (POM) 20/10/2022 HANBET PHARMACEUTICALS LIMITED, , MURTALA MOHAMMED WAY, EBUTE-METTA LAGOS 8165579447 hanbetpharm@yahoo.com JIANGSU RUINIAN QIANJIN PHARMACEUTICAL COMPANY LIMITED., CHUANBU VILLAGE, DINGSHU TOWN, YIXING CITY, YIXING, JIANGSU, CHINA., China	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7653